Skip to content

Efficacy and Safety of Qizi Yuzhi Granules in Women with Diminished Ovarian Reserve and Kidney Qi Deficiency in IVF-ET Outcomes (EQUATION): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Trial

Efficacy and Safety of Qizi Yuzhi Granules in Women with Diminished Ovarian Reserve and Kidney Qi Deficiency in IVF-ET Outcomes (EQUATION): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000663
Enrollment
Unknown
Registered
2026-03-20
Start date
2026-03-31
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diminished Ovarian Reserve (DOR)

Interventions

QZYS Group:Qizi Yusi Granules
Control Group:Placebo

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 44 Years

Inclusion criteria

Inclusion criteria: (1) Age = 35 years old; (2) Diminished ovarian reserve (DOR): basal antral follicle count (AFC) < 7 on ultrasound, serum basal follicle-stimulating hormone (FSH) 10-25 IU/L for two consecutive menstrual cycles, and serum anti-Müllerian hormone (AMH) < 1.1 ng/mL. At least two of the above three criteria must be met for a diagnosis of DOR; (3) Diagnosed with Kidney-Qi Deficiency Syndrome according to Traditional Chinese Medicine (TCM): 1) Main symptoms: infertility for a long time, light or sparse menstrual blood; 2) Concurrent symptoms: dizziness and tinnitus, decreased libido, lumbosacral pain, weakness and soreness of the legs and knees or heel pain; 3) Tongue and pulse: pale red tongue with thin white or scanty coating, deep and thready pulse in both chi positions. The main symptom is essential, and 2-3 concurrent symptoms must be met. Not all tongue or pulse characteristics are necessary. (4) First or second time undergoing IVF-ET treatment; (5) Voluntarily signed informed consent form.

Exclusion criteria

Exclusion criteria: (1) Age > 45 years old; (2) Body mass index (BMI) = 35kg/m2; (3) Congenital malformation of reproductive organs or acquired organic lesions; (4) Concomitant endocrine diseases such as polycystic ovarian syndrome, endometriosis, thyroid dysfunction, adrenal cortical hyperplasia, hyperprolactinemia, etc.; (5) Chromosomal structural or numerical abnormalities or a history of genetic diseases; (6) Use of other traditional Chinese medicine or steroidal hormones within the past three months; (7) Concomitant severe heart, liver, or kidney diseases or other systemic diseases; (8) Allergy to any component of the study medication.

Design outcomes

Primary

MeasureTime frame
Cumulative live birth rate;

Secondary

MeasureTime frame
Cycle Cancellation Rate;Number of Oocytes Retrieved;Embryo Implantation Rate;Pregnancy Loss Rate;Live Birth Rate;

Countries

China

Contacts

Public ContactSun Zhen-Gao

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

sunzhengao77@126.com13708938621

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026